SCHEMBL31566496

SCHEMBL31566496

CN1C[C@@H]2CN(C(=O)OC(C)(C)C)C[C@H]2C1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 1/20 0.60
USP2 O75604 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
HPGD P15428 1/20 0.42
HDAC1 Q13547 1/20 0.41
HDAC2 Q92769 1/20 0.41
GPR119 Q8TDV5 3/20 0.41
RECQL P46063 1/20 0.41
EPHX1 P07099 1/20 0.41
HSD11B1 P28845 1/20 0.40
DDB1 Q16531 1/20 0.40
CRBN Q96SW2 1/20 0.40
NAMPT P43490 1/20 0.40
CHRM2 P08172 1/20 0.40
CHRM1 P11229 1/20 0.40
CHRM3 P20309 1/20 0.40
MEN1 O00255 1/20 0.39
ALDH1A1 P00352 1/20 0.39
MAPT P10636 1/20 0.39
KMT2A Q03164 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2966871 1.00 NR1H2 (0.60) NR1H2USP2SMN1; SMN2HPGDHDAC1
SCHEMBL14325258 1.00 NR1H2 (0.60) NR1H2USP2SMN1; SMN2HPGDHDAC1
SCHEMBL15495236 1.00 NR1H2 (0.60) NR1H2USP2SMN1; SMN2HPGDHDAC1
SCHEMBL16348045 0.93 NR1H2 (0.54) NR1H2USP2SMN1; SMN2HPGDHDAC1
SCHEMBL17518861 0.88 GPR119 (0.49) NR1H2HPGDHDAC1HDAC2GPR119
SCHEMBL15078689 0.88 GPR119 (0.49) NR1H2HPGDHDAC1HDAC2GPR119
SCHEMBL22873431 0.87 NR1H2 (0.48) NR1H2USP2SMN1; SMN2HPGDGPR119
SCHEMBL25269687 0.86 NR1H2 (0.54) NR1H2USP2SMN1; SMN2HPGDGPR119
SCHEMBL23763034 0.86 GPR119 (0.57) USP2SMN1; SMN2HPGDGPR119RECQL
SCHEMBL17518845 0.85 MEN1 (0.51) NR1H2USP2SMN1; SMN2HPGDHDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025096637-A1 SUBSTITUTED ARYL SULFONAMIDES FOR USE AS SODIUM CHANNEL INHIBITORS XENON PHARMACEUTICALS INC. (CA) 2025-05-08 WO disclosed